International Clinical Trial: Metabolomics-Based Cohort Study of Natural Progression and Risk Factors Associated with Pathological Myopia

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131781) titled 'Metabolomics-Based Cohort Study of Natural Progression and Risk Factors Associated with Pathological Myopia' on Sept. 6.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: First Affiliated Hospital of Kunming Medical University

Condition: Pathological myopia (PM)

Intervention: Normal control group:None Group of patients with pathological myopia:None Pathological Myopia Group (PM Group):None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-06

Target Sample Size: Normal control group:100;Group of patients with pathological myopia:100;Pathologica...